741 related articles for article (PubMed ID: 33067551)
1. Prevalence and factors associated with multidrug-resistant tuberculosis in South India.
Shivekar SS; Kaliaperumal V; Brammacharry U; Sakkaravarthy A; Raj CKV; Alagappan C; Muthaiah M
Sci Rep; 2020 Oct; 10(1):17552. PubMed ID: 33067551
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy and usefulness of the Genotype MTBDRplus assay in diagnosing multidrug-resistant tuberculosis in Cameroon? a cross-sectional study.
Abanda NN; Djieugoué JY; Lim E; Pefura-Yone EW; Mbacham WF; Vernet G; Penlap VM; Eyangoh SI; Taylor DW; Leke RGF
BMC Infect Dis; 2017 May; 17(1):379. PubMed ID: 28569148
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in India.
Yadav RN; Singh BK; Sharma SK; Sharma R; Soneja M; Sreenivas V; Myneedu VP; Hanif M; Kumar A; Sachdeva KS; Paramasivan CN; Vollepore B; Thakur R; Raizada N; Arora SK; Sinha S
PLoS One; 2013; 8(9):e72036. PubMed ID: 24039735
[TBL] [Abstract][Full Text] [Related]
4. Profile of drug-resistant-conferring mutations among new and previously treated pulmonary tuberculosis cases from Aligarh region of Northern India.
Ahmed S; Shukla I; Fatima N; Varshney SK; Shameem M; Tayyaba U
Int J Mycobacteriol; 2018; 7(4):315-327. PubMed ID: 30531028
[TBL] [Abstract][Full Text] [Related]
5. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
Pitso L; Potgieter S; Van der Spoel van Dijk A
S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
[TBL] [Abstract][Full Text] [Related]
7. Frequency of multi-drug resistance and mutations in Mycobacterium tuberculosis isolates from Punjab state of India.
Singhal R; Arora J; Sah GC; Bhalla M; Sarin R; Prasad Myneedu V
J Epidemiol Glob Health; 2017 Sep; 7(3):175-180. PubMed ID: 28756826
[TBL] [Abstract][Full Text] [Related]
8. Differences in rpoB, katG and inhA mutations between new and previously treated tuberculosis cases using the GenoType MTBDRplus assay.
Alvarez-Uria G; Reddy R
Infect Genet Evol; 2018 Apr; 59():48-50. PubMed ID: 29413885
[TBL] [Abstract][Full Text] [Related]
9. Detection of multi-drug resistance & characterization of mutations in Mycobacterium tuberculosis isolates from North- Eastern States of India using GenoType MTBDRplus assay.
Singhal R; Myneedu VP; Arora J; Singh N; Sah GC; Sarin R
Indian J Med Res; 2014 Oct; 140(4):501-6. PubMed ID: 25488443
[TBL] [Abstract][Full Text] [Related]
10. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
Garg K; Saini V; Dhillon R; Agarwal P
Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
[TBL] [Abstract][Full Text] [Related]
12. Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand.
Suthum K; Samosornsuk W; Samosornsuk S
J Infect Dev Ctries; 2020 Mar; 14(3):268-276. PubMed ID: 32235087
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of the GenoType MTBDRplus VER 2.0 line probe assay for the detection of isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
Moga S; Bobosha K; Fikadu D; Zerihun B; Diriba G; Amare M; Kempker RR; Blumberg HM; Abebe T
PLoS One; 2023; 18(4):e0284737. PubMed ID: 37099514
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
Khurana P; Saigal K; Ghosh A
Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
[TBL] [Abstract][Full Text] [Related]
15. Early detection of multi-drug resistance and common mutations in Mycobacterium tuberculosis isolates from Delhi using GenoType MTBDRplus assay.
Singhal R; Myneedu VP; Arora J; Singh N; Bhalla M; Verma A; Sarin R
Indian J Med Microbiol; 2015 Feb; 33 Suppl():46-52. PubMed ID: 25657156
[TBL] [Abstract][Full Text] [Related]
16. Performance comparison of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains.
Al-Mutairi NM; Ahmad S; Mokaddas E
Int J Tuberc Lung Dis; 2011 Jan; 15(1):110-5. PubMed ID: 21276306
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and molecular characterization of multidrug-resistant M. tuberculosis in Jiangxi province, China.
Luo D; Chen Q; Xiong G; Peng Y; Liu T; Chen X; Zeng L; Chen K
Sci Rep; 2019 May; 9(1):7315. PubMed ID: 31086215
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
19. Molecular detection of multidrug resistance pattern and associated gene mutations in M. tuberculosis isolates from newly diagnosed pulmonary tuberculosis patients in Addis Ababa, Ethiopia.
Tilahun M; Shimelis E; Wogayehu T; Assefa G; Wondimagegn G; Mekonnen A; Hailu T; Bobosha K; Aseffa A
PLoS One; 2020; 15(8):e0236054. PubMed ID: 32750053
[TBL] [Abstract][Full Text] [Related]
20. Variations in rifampicin and isoniazid resistance associated genetic mutations among drug naïve and recurrence cases of pulmonary tuberculosis.
Kabir S; Junaid K; Rehman A
Int J Infect Dis; 2021 Feb; 103():56-61. PubMed ID: 33181327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]